CDH1 and breast cancer: Notably, in osteosarcoma and breast cancer, CYR61 controls the N-cadherin/E-cadherin ratio as well as the expression of other markers such as Snail, Slug, Vimentin, thereby favoring spheroid growth and cell invasion while impairing cell–cell and cell–matrix adhesion [68,69].